← Browse by Condition
Medical Condition
primary sjogren 39 s syndrome
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1
NCT07184450 Phase 1
Recruiting
Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases
Enrollment
11 pts
Location
China
Sponsor
Chongqing Precision Biotech Co...
NCT07167537 Phase 1
Recruiting
A Study of OL-CD19-GDT in Relapsed/ Refractory Autoimmune Diseases
Enrollment
44 pts
Location
China
Sponsor
Beijing GoBroad Hospital